A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.

by Jillian A Bristol, Reza Djavadian, Emily R Albright, Carrie B Coleman, Makoto Ohashi, Mitchell Hayes, James C Romero-Masters, Elizabeth A Barlow, Paul J Farrell, Rosemary Rochford, Robert F Kalejta, Eric C Johannsen, Shannon C Kenney
Published 2018-07-01

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.

by James C Romero-Masters, Shane M Huebner, Makoto Ohashi, Jillian A Bristol, Bayleigh E Benner, Elizabeth A Barlow, Gail L Turk, Scott E Nelson, Dana C Baiu, Nicholas Van Sciver, Erik A Ranheim, Jenny Gumperz, Nathan M Sherer, Paul J Farrell, Eric C Johannsen, Shannon C Kenney
Published 2020-02-01